10.19.2020

Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024, endangering 470 positions

Pfizer plans to ditch Perth sterile injectables manufacturing site by 2024, endangering 470 positions kblankenship Mon, 10/19/2020 - 11:03
10.19.2020

Developing a Toolkit to Assess Efficacy of Ebola Vaccines and Therapeutics

MCMi regulatory science project to research issues that are key to understanding and predicting if—and how—vaccines and therapeutics to prevent and treat Ebola will show efficacy
10.19.2020

For Our Vets LLC dba Patriot Supreme - 611043 - 10/16/2020

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
10.19.2020

Agios' Tibsovo has an FDA green light in AML. Why did European regulators turn it back?

Agios' Tibsovo has an FDA green light in AML. Why did European regulators turn it back? aliu Mon, 10/19/2020 - 09:38
10.19.2020

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report kblankenship Mon, 10/19/2020 - 08:33
10.16.2020

Patient Listening Sessions

Patient Listening Sessions led by FDA’s Patient Affairs Staff provide an opportunity for medical product Centers to engage with patients, caregivers, and their advocates about their experience with a disease or condition.
10.16.2020

FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia

Hematology / Oncology Approvals
10.16.2020

FDA extends approval of pembrolizumab for classical Hodgkin lymphoma

Hematology / Oncology Approvals
10.16.2020

Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment

Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment
10.16.2020

Pfizer CEO, facing pushback, shifts COVID-19 vaccine timeline to late November

Pfizer CEO, facing pushback, shifts COVID-19 vaccine timeline to late November aliu Fri, 10/16/2020 - 11:50